NDAINHALATIONGAS
Approved
Mar 1976
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
2/8 — Basic
XENON XE 133 (xenon xe-133) by Lantheus Medical Imaging is radiopharmaceutical activity [moa]. First approved in 1976.
Drug data last refreshed 18h ago · AI intelligence enriched 1w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Xenon XE-133 is a radioactive noble gas radiopharmaceutical administered via inhalation for diagnostic imaging of pulmonary ventilation and cerebral blood flow. It is a legacy nuclear medicine agent that has been in clinical use since 1976 for assessment of lung function and regional brain perfusion in patients with suspected pulmonary or neurological disorders.
LOE Approaching
As a legacy radiopharmaceutical with approaching loss of exclusivity, commercial teams are likely focused on defending market position in an increasingly specialized nuclear medicine niche.
Mechanism of Action
Radiopharmaceutical Activity
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on Xenon XE-133 offers stable but limited career momentum; roles are primarily focused on maintaining market share and managing decline in a niche diagnostic market. This product is better suited for mid-career specialists seeking stability over growth rather than early-career professionals seeking exponential advancement.
Specialty Sales RepresentativeProduct Manager
Worked on XENON XE 133 at Lantheus Medical Imaging? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.